# HCT+F vs. HCT Alone in Critically Ill Medical Septic Shock Patients

> **NCT03710187** · PHASE2 · COMPLETED · sponsor: **University of Tennessee Medical Center** · enrollment: 84 (actual)

## Conditions studied

- Septic Shock

## Interventions

- **DRUG:** Hydrocortisone

## Key facts

- **NCT ID:** NCT03710187
- **Lead sponsor:** University of Tennessee Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-05
- **Primary completion:** 2019-09-27
- **Final completion:** 2019-09-27
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2021-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03710187

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03710187, "HCT+F vs. HCT Alone in Critically Ill Medical Septic Shock Patients". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03710187. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
